Echo vs. EGDT in Severe Sepsis and Septic Shock
ECHO RCT
Echocardiography-Guided Resuscitation in Severe Sepsis and Septic Shock Vs. Early Goal-Directed Therapy: Pilot Study
1 other identifier
interventional
80
1 country
1
Brief Summary
Echocardiography (cardiac ultrasound) is being used more often in the critical care setting for management of severe infection (septic shock). Early studies show echocardiography to be useful in these patients, but at this time, there are no good clinical trials to justify its use. Our study goals/objectives are as follows:
- 1.To conduct an unblinded, two-group randomized controlled clinical trial to compare an echocardiography-guided resuscitation protocol with an Early Goal Directed Therapy (EGDT) protocol in patients with severe sepsis or septic shock.
- 2.Demonstrate that a sepsis treatment protocol using transthoracic echocardiography and other non-invasive assessments of cardiac output will result in more rapid resolution of septic shock compared to invasive EGDT.
- 3.Demonstrate patients receiving the non-invasive echocardiography protocol will receive less administration of intravenous fluid.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2014
CompletedStudy Start
First participant enrolled
December 1, 2014
CompletedFirst Posted
Study publicly available on registry
February 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedJuly 16, 2018
July 1, 2018
2.4 years
November 3, 2014
July 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Serial organ failure assessment (SOFA) scores in both treatment arms
up to 72 hours
Secondary Outcomes (5)
Inpatient mortality in both treatment arms
Up to ~7 days (Occurring during hospital stay).
Time to lactate clearance in both treatment arms
Up to ~7 days (Occurring during ICU hospital stay).
Number of ICU-Free days
28 days
Daily and cumulative fluid balance in both treatment arms
Up to ~7 days (Occurring during ICU hospital stay).
Number of ventilator-free days
Up to ~7 days (Occurring during ICU hospital stay).
Study Arms (2)
Early Goal Directed Therapy (EGDT)
ACTIVE COMPARATOREGDT is currently standard of care in management of septic shock, so assignment to this treatment arm will confer no additional risk above that of standard of care. EGDT utilizes placement of a central venous catheter, an arterial catheter, and administration of intravenous fluid and vasoactive medications. EGDT uses central venous catheter to assess central venous pressure and ScVO2.
Echo Guided Fluid Resuscitation
EXPERIMENTALThe echo arm also utilizes placement of a central venous catheter, an arterial catheter, and administration of intravenous fluid and vasoactive medications, all of which are interventions found in standard care. The central venous pressure will not be monitored in this arm. Instead, decisions for giving fluids will be directed by the results of Echocardiography. Echocardiography poses no known risk to the patient, and it is non-invasive. The only risk of echocardiography is that of misdiagnosis.
Interventions
Patients will have their fluid resuscitation care guided by measurements obtained during an echo.
Patients will have their fluid resuscitation care guided by an EGDT protocol, which is currently used as standard of care.
Eligibility Criteria
You may qualify if:
- At least 18 years of age
- Suspected infection
- Two or more systemic inflammatory response syndrome (SIRS) criteria
- White blood cell count less than 4,000 per mm3, greater than 12,000 per mm3, or differential with greater than 10% immature forms
- Heart rate greater than 90 beats per minute
- Respiratory rate greater than 20 breaths per minute or paCO2 less than 32 mmHg
- Temperature less than 36°C or greater than 38°C
- Evidence of refractory hypoperfusion attributed to sepsis (one or more of the following):
- Systolic blood pressure less than 90 mmHg despite an intravenous fluid challenge of at least 30ml/kg (a portion of this may be albumin equivalent)
- Blood lactate level at least 4 mmol/L.
- Intention to place an arterial catheter.
- Intention to place a central venous catheter.
You may not qualify if:
- Known pregnancy
- Requirement for immediate surgery
- Hypotension attributed to alternative cause
- Treating physician deems the patient is moribund
- Treating physician deems aggressive care is unsuitable
- Contraindication to central venous catheterization or arterial catheterization
- Advanced directives restricting implementation of the protocol
- Significant pathology of the chest or abdominal wall that would make transthoracic echocardiography impossible (burns, chest trauma, etc.)
- Children under the age of 18 will not be included in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Intermountain Medical Center
Murray, Utah, 84157, United States
Related Publications (1)
Lanspa MJ, Burk RE, Wilson EL, Hirshberg EL, Grissom CK, Brown SM. Echocardiogram-guided resuscitation versus early goal-directed therapy in the treatment of septic shock: a randomized, controlled, feasibility trial. J Intensive Care. 2018 Aug 13;6:50. doi: 10.1186/s40560-018-0319-3. eCollection 2018.
PMID: 30123511DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Lanspa, MD
Intermountain Health Care, Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2014
First Posted
February 3, 2015
Study Start
December 1, 2014
Primary Completion
May 1, 2017
Study Completion
October 1, 2017
Last Updated
July 16, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share